HomeCompareSYK vs PXD

SYK vs PXD: Dividend Comparison 2026

SYK yields 1.04% · PXD yields 4.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PXD wins by $1950.78M in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
PXD
PXD
● Live price
4.06%
Share price
$269.62
Annual div
$10.94
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1950.82M
Annual income
$1,862,635,547.63
Full PXD calculator →

Portfolio growth — SYK vs PXD

📍 PXD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKPXD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + PXD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
PXD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
PXD
Annual income on $10K today (after 15% tax)
$344.89/yr
After 10yr DRIP, annual income (after tax)
$1,583,240,215.49/yr
At 15% tax rate, PXD beats the other by $1,583,233,174.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + PXD for your $10,000?

SYK: 50%PXD: 50%
100% PXD50/50100% SYK
Portfolio after 10yr
$975.43M
Annual income
$931,321,915.31/yr
Blended yield
95.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PXD right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
PXD
Analyst Ratings
43
Buy
24
Hold
3
Sell
Consensus: Buy
Price Target
$254.09
-5.8% upside vs current
Range: $196.00 — $347.00
Altman Z
4.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
PXD buys
0
No recent congressional trades found for SYK or PXD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKPXD
Forward yield1.04%4.06%
Annual dividend / share$3.40$10.94
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%100%
Portfolio after 10y$43.3K$1950.82M
Annual income after 10y$8,282.98$1,862,635,547.63
Total dividends collected$21.0K$1944.52M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$428.67$254.09

Year-by-year: SYK vs PXD ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrPXD PortfolioPXD Income/yrGap
1← crossover$10,852$152.43$11,512$811.51$660.00PXD
2$11,838$226.03$14,063$1,746.12$2.2KPXD
3$13,004$336.89$19,035$3,987.30$6.0KPXD
4$14,420$505.63$30,455$10,087.67$16.0KPXD
5$16,195$766.09$62,755$30,167.77$46.6KPXD
6$18,504$1,175.64$183,339$116,191.48$164.8KPXD
7$21,635$1,835.40$830,668$634,494.75$809.0KPXD
8$26,082$2,932.10$6,262,177$5,373,362.05$6.24MPXD
9$32,737$4,829.68$82,416,983$75,716,453.96$82.38MPXD
10$43,312$8,282.98$1,950,821,719$1,862,635,547.63$1950.78MPXD

SYK vs PXD: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

PXDStock

Pioneer Natural Resources Company operates as an independent oil and gas exploration and production company in the United States. The company explores for, develops, and produces oil, natural gas liquids (NGLs), and gas. It has operations in the Midland Basin in West Texas. As of December 31, 2021, the company had proved undeveloped reserves and proved developed non-producing reserves of 130 million barrels of oil, 92 million barrels of NGLs, and 462 billion cubic feet of gas; and owned interests in 11 gas processing plants. Pioneer Natural Resources Company was founded in 1997 and is headquartered in Irving, Texas.

Full PXD Calculator →
📬

Get this SYK vs PXD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.